Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV003079124 | SCV003460077 | pathogenic | not provided | 2022-08-30 | criteria provided, single submitter | clinical testing | This missense change has been observed in individuals with autosomal dominant BEST1-related conditions (PMID: 29555955). This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 21 of the BEST1 protein (p.Leu21Arg). This variant is not present in population databases (gnomAD no frequency). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. This variant disrupts the p.Leu21 amino acid residue in BEST1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10737974, 21878505, 29668979). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
| Institute of Human Genetics, |
RCV004817222 | SCV005070452 | likely pathogenic | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing |